Roche licenses rights to Simcere Zaiming’s SIM-0660
Immune Simcere Zaiming Pharmaceutical Co. Ltd., a subsidiary of Simcere Pharmaceutical Group Ltd., has entered into an exclusive…
Simcere Zaiming Enters Exclusive License Agreement with Roche for SIM0660 Global Development
NANJING, China, Sept. 1, 2026 /PRNewswire/ — Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced…
Hanmi Pharmaceutical has decided to transfer its technology to “Genentech,” a subsidiary of Roche Gr..
Pre-payment without obligation to return KRW 260 billionExcluding Korea, conditions for transfer of copyrights worldwideWill be led by…